Please use this identifier to cite or link to this item: http://localhost:8080/xmlui/handle/123456789/556
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSingh, Shabya-
dc.date.accessioned2024-03-09T07:53:07Z-
dc.date.available2024-03-09T07:53:07Z-
dc.date.issued2022-
dc.identifier.urihttp://localhost:8080/xmlui/handle/123456789/556-
dc.language.isoen_USen_US
dc.publisherIIHMR Universityen_US
dc.subjectHospitalen_US
dc.subjectBiomarkeren_US
dc.subjectBiomarker as Clinical Endpointen_US
dc.subjectBiomarker in Drug Developmenten_US
dc.subjectDrug development Phaseen_US
dc.subjectSurrogate endpointen_US
dc.subjectBiomarker in Disease Drug Developmenten_US
dc.subjectPre-Clinical Biomarkeren_US
dc.titleTo Study the Role of Biomarkers in Drug Developmenten_US
dc.typeDissertationen_US
dc.guideDas, Arindamen_US
dc.organizationnameHealthark Insights Wellness Solutions LLPen_US
Appears in Collections:2022

Files in This Item:
File Description SizeFormat 
Shabya-dis.pdfDissertation Report675.74 kBAdobe PDF Preview PDFDownload
Shabya-ppt.pdfPresentation812.55 kBAdobe PDF Preview PDFDownload


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.